Top Stories
-
The breast imaging and surgical breast care programs are collecting items to create care packages for cancer patients undergoing chemotherapy.
Topic
-
In animal studies, warfarin, a widely used blood thinner, shrinks tumors by promoting a self-destruct mechanism in cancer cells.
-
Columbia cancer researchers have discovered how melanoma can hide from our immune system, pointing to ways drug developers might restore the tumor’s vulnerability.
-
The Irving Institute for Clinical and Translational Research announced four new Herbert and Florence Irving Scholars for the 2023-2026 cohort.
Topic
Latest News
- June 30, 2023
An oral microbiologist who collaborates with dentists and doctors discovers what our bodies already knew: Everything is connected.
Topic
- June 14, 2023
The School of Nursing's Phoenix Matthews shares how they merged once-separate identities as psychologist and activist to fight cancer-related health disparities in underserved populations.
Topic
- April 14, 2023
Columbia researchers have shined new light on how the “dark” part of the genome allows cancer cells to be detected by the immune system, which could lead to better immunotherapies.
- March 9, 2023
Columbia’s researchers have opened a trial of a noninvasive, focused ultrasound approach to open the blood-brain barrier, enabling higher concentrations of an effective drug to enter the brain.
Topic
- February 23, 2023
In the past decade, physicians have recommended that women undergoing some surgeries have their fallopian tubes removed at the same time to prevent ovarian cancer.
Topic
- January 20, 2023
Columbia expert Dr. Fatemeh Momen-Heravi shares facts about HPV-related cancer risk factors and prevention.
Topic
- December 13, 2022
A significantly lower proportion of Hispanic and Black women who underwent screening received 3D mammograms, according to a new study presented at the 2022 San Antonio Breast Cancer Symposium.
Topic
- November 30, 2022
A recent rise in a rare lymphoma has been linked to breast implants, but Columbia researchers have found that the risk is extremely low among women who have reconstructive surgery after mastectomy.
Topic
- November 28, 2022
Bad weather forced the cancellation of the in-person cycling fundraiser, but participants organized their own bike rides and raised $1.1 million for cancer research and patient care at Columbia.
Topic
- November 16, 2022
Jan Hilgeman is one of the rare long-term survivors of pancreatic cancer, and Columbia researchers are now studying her cells in hopes of developing a potential treatment for others with the disease.
